Provectus Biopharmaceuticals Price on December 22, 2024
PVCTDelisted Stock | USD 0.11 0.00 0.00% |
If you're considering investing in Provectus OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Provectus Biopharmaceutica stands at 0.11, as last reported on the 22nd of December, with the highest price reaching 0.11 and the lowest price hitting 0.11 during the day. We have found nineteen technical indicators for Provectus Biopharmaceutica, which you can use to evaluate the volatility of the company. Please check Provectus Biopharmaceutica's Coefficient Of Variation of (1,840), risk adjusted performance of (0.03), and Variance of 32.57 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Provectus OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Provectus |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
PVCT |
Based on monthly moving average Provectus Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Provectus Biopharmaceutica by adding Provectus Biopharmaceutica to a well-diversified portfolio.
Related Headline
Scholar Rock Headline on 22nd of December 2024
Disposition of 208272 shares by Invus Public Equities, L.p. ... by Invus Public Equities, L.p.
Filed transaction by Scholar Rock Holding 10 Percent Owner. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Provectus Biopharmaceutica Valuation on December 22, 2024
It is possible to determine the worth of Provectus Biopharmaceutica on a given historical date. On December 22, 2024 Provectus was worth 0.11 at the beginning of the trading date compared to the closed value of 0.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Provectus Biopharmaceutica otc stock. Still, in general, we apply an absolute valuation method to find Provectus Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Provectus Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Provectus Biopharmaceutica's related companies.
Open | High | Low | Close | Volume | |
12/22/2024 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00 |
Backtest Provectus Biopharmaceutica | | | Provectus Biopharmaceutica History | | | Provectus Biopharmaceutica Valuation |
Provectus Biopharmaceutica Trading Date Momentum on December 22, 2024
Provectus Biopharmaceutica Fundamentals Correlations and Trends
By evaluating Provectus Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Provectus Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Provectus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Provectus Biopharmaceutica OTC Stock history
Provectus Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Provectus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Provectus Biopharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Provectus Biopharmaceutica stock prices may prove useful in developing a viable investing in Provectus Biopharmaceutica
Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. Provectus Biopharmaceuticals, Inc. was incorporated in 2002 and is based in Knoxville, Tennessee. Provectus Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Provectus Biopharmaceutica OTC Stock Technical Analysis
Provectus Biopharmaceutica technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Provectus Biopharmaceutica Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Provectus Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Provectus Biopharmaceutica December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Provectus Biopharmaceutica otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Provectus Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Provectus Biopharmaceutica otc stock market strength indicators, traders can identify Provectus Biopharmaceuticals entry and exit signals to maximize returns
Provectus Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Provectus Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Provectus OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Provectus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.48) | |||
Treynor Ratio | (0.71) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Provectus Biopharmaceutica information on this page should be used as a complementary analysis to other Provectus Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Provectus OTC Stock
If you are still planning to invest in Provectus Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Provectus Biopharmaceutica's history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |